GAMCO Investors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-2,776
| Closed | -$214K | – | 878 |
|
|
2020
Q2 | $214K | Sell |
2,776
-7,180
| -72% | -$550K | ﹤0.01% | 787 |
|
|
2020
Q1 | $744K | Buy |
+9,956
| New | +$688K | 0.01% | 592 |
|
|
2019
Q4 | – | Sell |
-5,880
| Closed | -$373K | – | 917 |
|
|
2019
Q3 | $373K | Sell |
5,880
-1,050
| -15% | -$68.6K | ﹤0.01% | 776 |
|
|
2019
Q2 | $468K | Sell |
6,930
-2,570
| -27% | -$169K | ﹤0.01% | 741 |
|
|
2019
Q1 | $618K | Sell |
9,500
-3,380
| -26% | -$225K | ﹤0.01% | 647 |
|
|
2018
Q4 | $806K | Sell |
12,880
-2,000
| -13% | -$140K | 0.01% | 574 |
|
|
2018
Q3 | $1.15M | Sell |
14,880
-100
| -0.7% | -$7.55K | 0.01% | 563 |
|
|
2018
Q2 | $1.06M | Buy |
14,980
+2,000
| +15% | +$141K | 0.01% | 564 |
|
|
2018
Q1 | $979K | Sell |
12,980
-600
| -4% | -$47.7K | 0.01% | 560 |
|
|
2017
Q4 | $973K | Hold |
13,580
| – | – | 0.01% | 576 |
|
|
2017
Q3 | $1.1M | Sell |
13,580
-500
| -4% | -$38.2K | 0.01% | 562 |
|
|
2017
Q2 | $997K | Hold |
14,080
| – | – | 0.01% | 581 |
|
|
2017
Q1 | $956K | Buy |
14,080
+1,666
| +13% | +$117K | 0.01% | 581 |
|
|
2016
Q4 | $889K | Hold |
12,414
| – | – | 0.01% | 586 |
|
|
2016
Q3 | $982K | Sell |
12,414
-23,405
| -65% | -$1.9M | 0.01% | 582 |
|
|
2016
Q2 | $2.99M | Sell |
35,819
-4,871
| -12% | -$432K | 0.02% | 451 |
|
|
2016
Q1 | $3.74M | Sell |
40,690
-2,010
| -5% | -$181K | 0.02% | 410 |
|
|
2015
Q4 | $4.32M | Sell |
42,700
-1,050
| -2% | -$109K | 0.03% | 388 |
|
|
2015
Q3 | $4.3M | Sell |
43,750
-175
| -0.4% | -$19.4K | 0.03% | 391 |
|
|
2015
Q2 | $5.14M | Sell |
43,925
-5,545
| -11% | -$606K | 0.03% | 392 |
|
|
2015
Q1 | $4.85M | Buy |
49,470
+6,870
| +16% | +$698K | 0.03% | 405 |
|
|
2014
Q4 | $4.01M | Hold |
42,600
| – | – | 0.02% | 428 |
|
|
2014
Q3 | $4.54M | Sell |
42,600
-6,570
| -13% | -$643K | 0.02% | 415 |
|
|
2014
Q2 | $4.08M | Buy |
49,170
+4,930
| +11% | +$384K | 0.02% | 423 |
|
|
2014
Q1 | $3.13M | Buy |
44,240
+10,635
| +32% | +$834K | 0.02% | 457 |
|
|
2013
Q4 | $2.52M | Buy |
33,605
+2,300
| +7% | +$160K | 0.01% | 481 |
|
|
2013
Q3 | $1.97M | Buy |
31,305
+9,505
| +44% | +$568K | 0.01% | 516 |
|
|
2013
Q2 | $1.12M | Buy |
+21,800
| New | +$1.14M | 0.01% | 566 |
|
Other funds holding GILD
GAMCO Investors's GILD Position: Q3 2020 in Review
GAMCO Investors sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 2,776 shares — an estimated $214K sold.
GAMCO Investors first reported a position in GILD in Q2 2013 and held it in 28 quarters. The position peaked at $5.14M in Q2 2015. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.
- GAMCO Investors reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
- GAMCO Investors sold 2,776 Gilead Sciences shares in Q3 2020, an estimated $214K.
- GAMCO Investors first reported a position in Gilead Sciences in Q2 2013 and held it in 28 quarters.
- GAMCO Investors's Gilead Sciences position peaked at $5.14M in Q2 2015.
- 1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.
Based on GAMCO Investors's 13F filing for Q3 2020, filed 6 Nov 2020.